Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial
Recruiting · NCT04852198 · Interventional (participants receive a specific treatment) · Lead sponsor: Flevoziekenhuis
View the official record on ClinicalTrials.gov →Interventions studied
OAGBRYGB
What this trial is about
The purpose of this study is to assess the safety and efficiency of OAGB compared to RYGB
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- body-mass index (BMI) of 40 kg/m2 or higher, or 35 kg/m2 or higher with the presence of at least one comorbidity (type 2 diabetes, high blood pressure, obstructive sleep apnoea, dyslipidaemia, osteoarthritis of the hip or knee)
- a positive evaluation by our BMDT
Exclusion criteria
- Presence of H. Pylori, resistant to eradication therapy
- chronic diarrhoea
- history of previous bariatric or extensive abdominal surgery
Where it is running
2 locations listed.
- Flevoziekenhuis - Almere Stad, Netherlands
- OLVG - Amsterdam, Netherlands